Compare · head to head
Aclaris Therapeutics vs Nurix Therapeutics
Aclaris Therapeutics ranks higher overall — 360 rank 28 vs 18.
Nurix Therapeutics leads on Growth (54 vs 45). Aclaris Therapeutics leads on Sentiment (62 vs 45). The two are close on Value, Quality and Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Biotechnology |
| Size | Small | Small |
| ISIN | US00461U1051 | US67080M1036 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 28 | 18 |
| Value | 42 | 38 |
| Quality | 32 | 35 |
| Growth | 45 | 54 |
| Safety | 45 | 43 |
| Sentiment | 62 | 45 |
| Quality details | ||
| Profitability | 19 | 26 |
| Cash Truth | 46 | 43 |
Aclaris Therapeutics vs Syndax PharmaceuticalsAclaris Therapeutics vs XencorAclaris Therapeutics vs Regeneron PharmaceuticalsAclaris Therapeutics vs Spero TherapeuticsAdd a third stock →
Full analyses: Aclaris Therapeutics · Nurix Therapeutics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100